Notice Number: NOT-AI-18-011

Key Dates
Release Date: January 10, 2018

Issued by
National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

Sample The purpose of this Notice is to clarify the Research Objectives and Scope section of RFA-AI-17-042, Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed).

Part 2. Full Text of Announcement
Section I. Funding Opportunity Description

Research Objectives and Scope

Current Language:

Examples of translational Center themes include, but are not limited to, the following areas:

• New or improved therapeutic(s) against antimicrobial-resistant pathogens.
• Development of a multivalent (e.g. broadly cross-protective or "universal") vaccine.
• Host-targeted interventions as therapeutics.
• Development of broad-spectrum countermeasures against taxonomically-related viruses.
• New or improved vaccine technologies or production platforms.
• Development of a broad-spectrum countermeasure technology.
• Co-development of a new therapeutic and associated diagnostic.

Revised Language:

Examples of translational Center themes include, but are not limited to, the following areas:

• New or improved therapeutic(s) against antimicrobial-resistant pathogens.
• Development of a multivalent (e.g. broadly cross-protective or "universal") vaccine.
• Host-targeted interventions as therapeutics.
• Development of broad-spectrum countermeasures against taxonomically-related viruses.
• New or improved vaccine technologies or production platforms.
• Development of a broad-spectrum countermeasure technology.
• Co-development of a new therapeutic and associated diagnostic platform (as defined below) for antimicrobial-resistant bacterial pathogens.

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to: